23.01.2008 15:00:00
|
Bausch & Lomb Names Gerald M. Ostrov Chairman and Chief Executive Officer
Bausch & Lomb announced today that it has named Gerald M. Ostrov as
chairman and chief executive officer, effective immediately. Most
recently, Mr. Ostrov was company group chairman, Worldwide Vision Care,
for Johnson & Johnson, where he led the company’s
global Vision Care businesses from 1998 to 2006.
Current Chairman and CEO Ronald L. Zarrella, 58, will retire in March
and serve as chairman emeritus.
"It has been a privilege to serve as Bausch &
Lomb’s chairman and CEO since 2001,”
said Mr. Zarrella. "Working with thousands of
highly talented employees worldwide, we were able to grow every aspect
of the company while enhancing its reputation as the world’s
premier eye health brand. Jerry has extensive experience in ophthalmic
businesses and consumer marketing, and is the ideal leader to take
Bausch & Lomb into a new era of growth.”
Mr. Ostrov, 58, first joined Johnson & Johnson in 1976, before leaving
for Ciba-Geigy AG in 1982. He was named president, Ciba Consumer
Pharmaceuticals, in 1985. In 1991, he returned to Johnson & Johnson as
president of its Personal Products business, and then became company
group chairman for its North American Consumer and Personal Care
businesses.
"It’s an honor to
lead Bausch & Lomb into a growth period, one that we believe will be
marked by considerable success across the vision care, pharmaceutical
and surgical businesses,” said Mr. Ostrov. "I’m
impressed by the passion of the company’s
employees, and its strong relationships with industry partners and
customers. We’re going to build upon an
unparalleled 155-year-old foundation of trust and innovation.”
Mr. Ostrov continued, "Warburg Pincus’
commitment to a long-term investment horizon, and the collaborative
relationship it has quickly built with Bausch & Lomb, is empowering the
company to grow. This week’s eyeonics
acquisition announcement is testament to our positive momentum.”
Elizabeth H. Weatherman, a Warburg Pincus managing director and member
of the Bausch & Lomb Board of Directors, commented, "We
thank Ron for his dedication to Bausch & Lomb. He was instrumental in
growing all aspects of the business, in leading the company through the
2006 recall, and then reestablishing widespread momentum —
an element vital for the organization’s
continued success. Jerry’s extraordinary
knowledge of the eye health industry will be instrumental as he leads
Bausch & Lomb into an extended period of growth.”
Mr. Ostrov holds an M.B.A. from Harvard University and a B.S. degree in
industrial engineering and operations research from Cornell University.
Bausch & Lomb is the eye health company dedicated to perfecting vision
and enhancing life for consumers around the world. Its core businesses
include soft and rigid gas permeable contact lenses and lens care
products, and ophthalmic surgical and pharmaceutical products. The
Bausch & Lomb name is one of the best known and most respected
healthcare brands in the world. Founded in 1853, the Company is
headquartered in Rochester, N.Y., and employs approximately 13,000
people worldwide. Its products are available in more than 100 countries.
More information about the Company can be found at www.bausch.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Bausch & Lomb Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |